GENERALI, Daniele

GENERALI, Daniele  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 1-gen-2016 Roviello, Giandomenico; Milani, Manuela; Gobbi, Angela; Cappelletti, Maria Rosa; Zanotti, Laura; Senti, Chiara; Bottini, Alberto; Strina, Carla; Sigala, Sandra; Generali, Daniele
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 1-gen-2023 Sobhani, Navid; Bouchè, Victoria; Aldegheri, Giovanni; Rocca, Andrea; D’Angelo, Alberto; Giudici, Fabiola; Bottin, Cristina; Donofrio, Carmine Antonio; Pinamonti, Maurizio; Ferrari, Benvenuto; Panni, Stefano; Cominetti, Marika; Aliaga, Jahard; Ungari, Marco; Fioravanti, Antonio; Zanconati, Fabrizio; Generali, Daniele
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 1-gen-2002 Franceschini, Franco; Cavazzana, Ilaria; Generali, Daniele; Quinzanini, Marzia; Viardi, Luigi; Ghirardello, Anna; Doria, Andrea; Cattaneo, Roberto
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. 1-gen-2015 Bazzola, L; Foroni, C; Andreis, D; Zanoni, V; R., Cappelletti M; Allevi, G; Aguggini, S; Strina, C; Milani, M; Venturini, S; Ferrozzi, F; Giardini, R; Bertoni, R; Turley, H; Gatter, K; Petronini, Pg; Fox, Sb; Harris, Al; Martinotti, M; Berruti, Alfredo; Bottini, Alberto; Reynolds, Ar; Generali, Daniele
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 1-gen-2016 Roviello, Giandomenico; Sigala, Sandra; Danesi, Romano; del Re, Marzia; Bonetta, Alberto; Cappelletti, Maria Rosa; Zanotti, Laura; Bottini, Alberto; Generali, Daniele
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 1-gen-2015 Amoroso, V.; Generali, D.; Buchholz, T.; Cristofanilli, M.; Pedersini, R.; Curigliano, G.; Daidone, M. G.; Di Cosimo, S.; Dowsett, M.; Fox, S.; Harris, A. L.; Makris, A.; Vassalli, L.; Ravelli, A.; Cappelletti, M. R.; Hatzis, C.; Hudis, C. A.; Pedrazzoli, P.; Sapino, A.; Semiglazov, V.; Von Minckwitz, G.; Simoncini, E. L.; Jacobs, M. A.; Barry, P.; Kuhn, T.; Darby, S.; Hermelink, K.; Symmans, F.; Gennari, A.; Schiavon, G.; Dogliotti, L.; Berruti, A.; Bottini, A.
Posterior petrous meningiomas: surgical classification and postoperative outcomes in a case series of 130 patients operated via the retrosigmoid approach 1-gen-2022 Donofrio, Carmine Antonio; Badaloni, Filippo; Riccio, Lucia; Morandini, Alessandro; Bertuccio, Alessandro; Generali, Daniele; Calbucci, Fabio; Servadei, Franco; Fioravanti, Antonio
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 1-gen-2016 Roviello, Giandomenico; Sigala, Sandra; Sandhu, Shahneen; Bonetta, Alberto; Cappelletti, Maria Rosa; Zanotti, Laura; Bottini, Alberto; Sternberg, Cora N.; Fox, Stephen B.; Generali, Daniele